Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

This appointment is a slap in the face to every health care professional who has spent their lives working to protect ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

To attract and retain workers, employers will focus on competitive salaries and flexible benefits, experts say.

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...